Three months ago we were stunned to learn, and report, that the Swiss National Bank – a central bank – had been one of the biggest buyers of AAPL stock in the first quarter, when it added 3.3 million shares to its existing position, or 60%, bringing the total to 9 million shares, for a…
With the exception of the bond sell-off yesterday, the markets behaved reasonably well – even in thin summer trading. This comes after Federal Reserve Bank of Atlanta President Dennis Lockhart’s comments that the Fed is poised to raise rates. Today, we saw a mixed Asian session for equities with both the Nikkei and HSI ending with small gains (+0.45%) whilst…
I should start by saying I have a short bias. It’s not a clear cut play given the dominance of trading ranges since the start of the year, but sellers may be looking to turn the screw. Holiday volumes will keep things scrappy into September, but markets may get a kicker before then. The most…
GoDaddy Inc. (GDDY – Snapshot Report) operates in the internet services space. The company is the world’s largest domain registrar, and has over 59 million domain names under management. During the market day, GoDaddy stock surged 3%, suggesting that investors were optimistic going into the earnings report. Our consensus estimate hasn’t changed in…
Is oil right now the biggest threat to the overall market? On Monday, oil fell to the lowest level since March as traders worried about signs of weak demand and increasing supplies. Chevron (CVX) and Exxon Mobil (XOM) were among the biggest decliners in the Dow Jones industrial average. As much as we would like…
Tesla Motors (TSLA – Analyst Report) reported Q2 loss and revenues after the bell, and results were mixed. The company reported a loss of 82 cents per share (accounting for stock-based compensation and other before non-recurring items) on $1.2 billion in quarterly sales. But Tesla shares are down in late-market trading based on lower deliveries…
Giant pharmaceutical companies like Pfizer (NYSE: PFE) and Merck (NYSE: MRK) are favorites of income-seekers, as they have historically paid high dividend yields. Is the next Pfizer or Merck out there somewhere? Amgen (Nasdaq: AMGN) is a biotech company whose $132 billion market cap is larger than that of many large blue-chip pharmas, including Bristol-Myers Squibb (NYSE: BMY), Abbott…
There was intraday commentary here about a large number of ounces of gold taken in delivery yesterday, and JP Morgan’s heroic attempt to fill the gap between paper and physical bullion at the last minute. And yet these numbers are barely rounding errors compared to the global physical markets centered in Europe, the Mideast and Asia. That is what seems so…
It appears faith in the hyper-growth names is fading. Tesla is down 8% after hours after humans parsed through its various non-GAAP shenanigans and found: *TESLA 2Q ADJ. TOTAL GROSS MARGIN 23.4%, EST. 26.2% *TESLA SEES YR DELIVERIES 50K-55K MODEL S & X; SAW ABOUT 55K Not close to whispor numbers and fears of model…
Tesla Motors Inc (NASDAQ:TSLA) released its second quarter earnings report after closing bell tonight, posting adjusted losses of 48 cents per share on non-GAAP revenue of $1.2 billion. Analysts had been looking for losses of 60 cents per share and $1.19 billion in revenue. In last year’s second quarter, the automaker reported earnings of 11 cents…
